Tvardi Therapeutics, Inc. (TVRD)
2.86
-0.03
(-1.04%)
USD |
NASDAQ |
Jun 08, 16:00
2.86
0.00 (0.00%)
After-Hours: 19:28
Tvardi Therapeutics EPS Diluted (Quarterly) : -0.7253 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.815 |
| Assertio Holdings, Inc. | -2.931 |
| Eli Lilly & Co. | 8.255 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.804M |
| Total Expenses (Quarterly) | 6.804M |
| Enterprise Value | 2.305M |
| Earnings Yield | -108.2% |
| Normalized Earnings Yield | -145.12 |